Lymphoma: Difference between revisions

Jump to navigation Jump to search
Line 68: Line 68:
**[[T-cell large granular lymphocyte leukemia|T cell large granular lymphocytic leukemia]]
**[[T-cell large granular lymphocyte leukemia|T cell large granular lymphocytic leukemia]]
**Aggressive NK cell leukemia
**Aggressive NK cell leukemia
**[[Adult T cell leukemia|Adult T cell leukemia/lymphoma (ATLL)]]
**[[Adult T-cell leukemia|Adult T-cell leukemia/lymphoma (ATLL)]]
**Extranodal NK/T cell lymphoma, nasal type
**Extranodal NK/T cell lymphoma, nasal type
**Enteropathy-type T cell lymphoma
**Enteropathy-type T cell lymphoma

Revision as of 08:52, 27 February 2010

For patient information click here

Lymphoma
Lymph node: Malignant Lymphoma Large Cell Type: Gross natural color excellent view of cut mesentery showing massively enlarged mesenteric nodes with focal hemorrhages case diagnosed several years ago as reticulum cell sarcoma excellent demonstration of nodes with lymphoma.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10 C81-C96
ICD-O: 9590-9999
MeSH D008223

WikiDoc Resources for Lymphoma

Articles

Most recent articles on Lymphoma

Most cited articles on Lymphoma

Review articles on Lymphoma

Articles on Lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lymphoma

Images of Lymphoma

Photos of Lymphoma

Podcasts & MP3s on Lymphoma

Videos on Lymphoma

Evidence Based Medicine

Cochrane Collaboration on Lymphoma

Bandolier on Lymphoma

TRIP on Lymphoma

Clinical Trials

Ongoing Trials on Lymphoma at Clinical Trials.gov

Trial results on Lymphoma

Clinical Trials on Lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lymphoma

NICE Guidance on Lymphoma

NHS PRODIGY Guidance

FDA on Lymphoma

CDC on Lymphoma

Books

Books on Lymphoma

News

Lymphoma in the news

Be alerted to news on Lymphoma

News trends on Lymphoma

Commentary

Blogs on Lymphoma

Definitions

Definitions of Lymphoma

Patient Resources / Community

Patient resources on Lymphoma

Discussion groups on Lymphoma

Patient Handouts on Lymphoma

Directions to Hospitals Treating Lymphoma

Risk calculators and risk factors for Lymphoma

Healthcare Provider Resources

Symptoms of Lymphoma

Causes & Risk Factors for Lymphoma

Diagnostic studies for Lymphoma

Treatment of Lymphoma

Continuing Medical Education (CME)

CME Programs on Lymphoma

International

Lymphoma en Espanol

Lymphoma en Francais

Business

Lymphoma in the Marketplace

Patents on Lymphoma

Experimental / Informatics

List of terms related to Lymphoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-in-Chief: Ross Bonander

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Lymphoma is a type of cancer that originates in lymphocytes (a type of white blood cell in the vertebrate immune system). There are many types of lymphoma. Lymphomas are part of the broad group of diseases called hematological neoplasms.

In the 19th and 20th centuries the affliction was called Hodgkin's Disease, as it was discovered by Thomas Hodgkin in 1832. Colloquially, lymphoma is broadly categorized as Hodgkin's lymphoma and non-Hodgkin lymphoma (all other types of lymphoma). Scientific classification of the types of lymphoma is more detailed.

Although older classifications referred to histiocytic lymphomas, these are recognized in newer classifications as of B, T or NK cell lineage. Histiocytic malignancies are rare and are classified as sarcomas.[1]

Prevalence

According to the U.S. National Institutes of Health, lymphomas account for about five percent of all cases of cancer in the United States, and Hodgkin's lymphoma in particular accounts for less than one percent of all cases of cancer in the United States.

Because the lymphatic system is part of the body's immune system, patients with a weakened immune system, such as from HIV infection or from certain drugs or medication, also have a higher incidence of lymphoma.

Classification

WHO classification

The WHO Classification is the latest classification of lymphoma, published by the World Health Organization in 2001.[1] It was based upon the "Revised European-American Lymphoma classification" (REAL).

This classification attempts to classify lymphomas by cell type, i.e. the normal cell type that most closely resembles the tumor. They are classified in three large groups: the B cell tumors, the T cell and natural killer cell tumors, Hodgkin lymphoma, and other minor groups: (ICD-O codes are provided where available)

Mature B cell neoplasms

DNA-microarray analysis of Burkitt's lymphoma and diffuse large B-cell lymphoma (DLBCL) showing differences in gene expression patterns. Colors indicate levels of expression; green indicates genes that are overexpressed in normal cells compared to lymphoma cells and red indicates genes that are overexpressed in lymphoma cells compared to normal cells.


Mature T cell and natural killer (NK) cell neoplasms

Hodgkin Lymphoma

    • Nodular lymphocyte-predominant Hodgkin lymphoma
    • Classical Hodgkin lymphoma
      • Nodular sclerosis
      • Mixed cellularity
      • Lymphocyte-rich
      • Lymphocyte depleted or not depleted

Immunodeficiency-associated lymphoproliferative disorders

    • Associated with a primary immune disorder
    • Associated with the Human Immunodeficiency Virus (HIV)
    • Post-transplant
    • Associated with Methotrexate therapy

Working formulation

The Working Formulation, published in 1982, is primarily descriptive. It is still occasionally used, but has been superseded by the WHO classification, above.

Low grade

High grade

Miscellaneous

Other classification systems

For diagnosis, etiology, staging, prognosis, and treatment

Please see separate links to Hodgkin's lymphoma and non-Hodgkin's lymphoma.

Genetics

Enteropathy associated T-cell lymphoma (EATL) is environmentally induced as a result of the consumption of Triticeae glutens. In gluten sensitive individuals with EATL 68% are homozygotes of the DQB1*02 subtype at the HLA-DQB1 locus (serotype DQ2).[2] (See Coeliac Disease, HLA-DQ, HLA DR3-DQ2)

See also

References

  1. 1.0 1.1 Pathology and Genetics of Haemo (World Health Organization Classification of Tumours S.). Oxford Univ Pr. ISBN 92-832-2411-6.
  2. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007). "Survival in Refractory Coeliac Disease and Enteropathy associated T cell Lymphoma: Retrospective evaluation of single centre experience". doi:10.1136/gut.2006.114512. PMID 17470479.

External links

Research Foundations

Information

Societies and Support Groups

Statistics

Template:Hematology

Template:SIB bg:Лимфома ar:سرطان الغدد الليمفاوية de:Malignes Lymphom eu:Linfoma ia:Lymphoma it:Linfoma he:לימפומה lt:Limfoma nl:Maligne lymfoom no:Lymfekreft fi:Lymfooma

Template:WikiDoc Sources